Environmentally Sustainable Solvents for Natural Pharmaceutical Extraction Processes. Australia supplies 25 per cent of the world's pain relieving medicinal opiates which contributes to a $200 million export industry for Australia. The active pharmaceutical ingredients are extracted and purified at GlaxoSmithKline’s (GSK) Port Fairy processing plant using a solvent extraction based process. Together with GSK the project team aim to examine the use of environmentally sustainable bio-derived natur ....Environmentally Sustainable Solvents for Natural Pharmaceutical Extraction Processes. Australia supplies 25 per cent of the world's pain relieving medicinal opiates which contributes to a $200 million export industry for Australia. The active pharmaceutical ingredients are extracted and purified at GlaxoSmithKline’s (GSK) Port Fairy processing plant using a solvent extraction based process. Together with GSK the project team aim to examine the use of environmentally sustainable bio-derived natural solvents to replace the volatile organic compound (VOC) fossil fuels based solvents used in the current process. Due to environmental and health concerns associated with VOCs the development of alternative solvents will be of great benefit to not only GSK but a range of other processing industries that also use VOC based solvent extraction processes.Read moreRead less
Granulation of hydrophobic powders: design and control of granule structure. This unique project will further enhance Australia's established world-class excellence in granulation research, and will assist in setting up a new school of excellence in granulation at Monash University. The innovative use of normally problematic material properties to produce 'designer granules' is a clear example of a 'Frontier Technologies' that can be used to develop 'Advanced Materials' for the next generation o ....Granulation of hydrophobic powders: design and control of granule structure. This unique project will further enhance Australia's established world-class excellence in granulation research, and will assist in setting up a new school of excellence in granulation at Monash University. The innovative use of normally problematic material properties to produce 'designer granules' is a clear example of a 'Frontier Technologies' that can be used to develop 'Advanced Materials' for the next generation of agricultural, food and pharmaceutical industries, particularly for delivery of hydrophobic drugs. The innovative ideas presented in this proposal are expected to provide multiple opportunities for collaboration with national and international research institutions and pharmaceutical companies. Read moreRead less
Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a p ....Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a precise size and narrow size distribution. This project aims to develop an innovative technology for the production of superior uniformly sized particulate drug delivery systems for the delivery of the "next generation" bioactives.Read moreRead less
Discrete particle simulation of powder dispersion in pharmaceutical aerosol inhalers. A successful completion of the project will i) greatly enhance the Australian R&D profile and capabilities of both computational modelling and pharmaceutical aerosol research in the world; ii) provide an improved delivery of therapeutic dose to patients via inhalers with better performance to enhance the therapeutic benefits; iii) enable wide availability of inexpensive and effective pharmaceutical inhalation p ....Discrete particle simulation of powder dispersion in pharmaceutical aerosol inhalers. A successful completion of the project will i) greatly enhance the Australian R&D profile and capabilities of both computational modelling and pharmaceutical aerosol research in the world; ii) provide an improved delivery of therapeutic dose to patients via inhalers with better performance to enhance the therapeutic benefits; iii) enable wide availability of inexpensive and effective pharmaceutical inhalation products to the Australian community for the treatment of asthma and other diseases, iv) facilitate environmentally friendly technology since powder aerosol delivery does not require any harmful organic solvents to operate.Read moreRead less
Synthesis of nanoparticles by impinging liquid-jet precipitation for inhalation drug delivery. The project aim is to develop a state of the art technology for the efficient, reliable and economical production of nanoparticles of drugs suitable for inhalation delivery to the lung. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. The project will focus on both the production process and the particle properties for aerosol a ....Synthesis of nanoparticles by impinging liquid-jet precipitation for inhalation drug delivery. The project aim is to develop a state of the art technology for the efficient, reliable and economical production of nanoparticles of drugs suitable for inhalation delivery to the lung. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. The project will focus on both the production process and the particle properties for aerosol administration. Successful development of the technology will not only gain new knowledge in the key area of nanotechnology, but also lead to better inhalation therapy to benefit patients.Read moreRead less
Development of a novel process for the formation of particles with controlled surface architecture for respiratory drug delivery. A successful conclusion of this project will enhance substantially the competitiveness of Australia's research in functional nanomaterials and advanced biomaterials. The Australian pharmaceutical industry will gain through the ability to develop proprietary pharmaceutical formulations targeted towards taking advantage of the novel process. Patients of asthma, lung inf ....Development of a novel process for the formation of particles with controlled surface architecture for respiratory drug delivery. A successful conclusion of this project will enhance substantially the competitiveness of Australia's research in functional nanomaterials and advanced biomaterials. The Australian pharmaceutical industry will gain through the ability to develop proprietary pharmaceutical formulations targeted towards taking advantage of the novel process. Patients of asthma, lung infection and other serious health problems will benefit from an improved delivery of therapeutic dose at a much reduced cost. The technology is environmentally friendly as powder aerosol delivery does not require any harmful organic solvent to operate.Read moreRead less
High Gravity Precipitation of Nanoparticles for Pulmonary Drug Delivery. This collaborative project aims to explore the huge market potential of drug delivery by inhalation aerosols using nanoparticles. It will apply cutting edge nanotechnology to develop new techniques using high gravity to synthesise particles of biomaterials suitable for inhalation. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. Successful developme ....High Gravity Precipitation of Nanoparticles for Pulmonary Drug Delivery. This collaborative project aims to explore the huge market potential of drug delivery by inhalation aerosols using nanoparticles. It will apply cutting edge nanotechnology to develop new techniques using high gravity to synthesise particles of biomaterials suitable for inhalation. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. Successful development of the technology will position both Australia and the industry partner to take a lead in the application of this novel technology in pharmaceutical aerosols, and provides better inhalation therapy to benefit patients.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0238094
Funder
Australian Research Council
Funding Amount
$197,000.00
Summary
Fine and Ultrafine Particle - Characterisation and Research Facility. The proposed grant aims to establish an integrated facility for characterising and researching fine and ultrafine particles. It will serve various research groups of three collaborating universities. Current facilities are limited to characterisation of liquid-borne particles down to 10 nm size. To extend the groups research interests into aerosols and nanoparticles the facilities requested in this grant are essential. Equipme ....Fine and Ultrafine Particle - Characterisation and Research Facility. The proposed grant aims to establish an integrated facility for characterising and researching fine and ultrafine particles. It will serve various research groups of three collaborating universities. Current facilities are limited to characterisation of liquid-borne particles down to 10 nm size. To extend the groups research interests into aerosols and nanoparticles the facilities requested in this grant are essential. Equipment critical for research into catalytic processes is also requested. Integration of the groups will create a force that institutions and industries,nation-wide, can turn to when the need for competent analytical and research solutions for particles and catalysis arises.Read moreRead less
Powder blending for dry powder inhalers: a new approach for direct control of powder structure. Over 80 per cent of pharmaceutical products involve the processing of powders. This project will generate new knowledge of how to assemble fine and cohesive particles into the structure required for dry powder inhaler products, leading to the development of new low-cost medicines in Australia and the Asia Pacific region.
Emulsion Stability and Solvent Extraction Equipment Design in the Pharmaceutical Industry. The project aims at developing reliable prediction of large scale performance of liquid extraction columns. This will be done through a study of the columns in operation at GlaxoSmithKline's operation at Port Fairy alkaloids plant. In addition a detailed study of the influence of impurities on the coalescence rate of liquid dispersions will be undertaken as this is an important rate limiting step in colu ....Emulsion Stability and Solvent Extraction Equipment Design in the Pharmaceutical Industry. The project aims at developing reliable prediction of large scale performance of liquid extraction columns. This will be done through a study of the columns in operation at GlaxoSmithKline's operation at Port Fairy alkaloids plant. In addition a detailed study of the influence of impurities on the coalescence rate of liquid dispersions will be undertaken as this is an important rate limiting step in column performance. The benefit to GlaxoSmithKline will be a more efficient and optimised plant. The benefit to Australian processing industries is a reliable method of relating small scale trials to full size column performance which is a significent problem in the minerals industry at present.Read moreRead less